Mandated coverage of preventive care and reduction in disparities: Evidence from colorectal cancer screening

American Journal of Public Health

Volumn 105, Issue , 2015, Pages S508-S516

  Hamman, Mary K ^a   Kapinos, Kandice A ^b  

^a UNIVERSITY OF WISCONSIN LA CROSSE   (United States)

^b RAND CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DIAGNOSIS; ETHNOLOGY; FEMALE; HEALTH CARE DISPARITY; HUMAN; INSURANCE; MALE; MASS SCREENING; MIDDLE AGED; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; UNITED STATES;

AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HEALTHCARE DISPARITIES; HUMANS; INSURANCE COVERAGE; MALE; MASS SCREENING; MIDDLE AGED; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84937397113     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2015.302578     Document Type: Article

References (46)

1. Winawer SJ. Colorectal cancer screening comes of age. N Engl J Med. 1993;328(19):1416-1417.
2. Wolff WI. Colonoscopy: history and development. Am J Gastroenterol. 1989;84(9):1017-1025.
3. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008;58(3):130-160.
4. Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM. American College of Gastroenterology guidelines for colorectal cancer screening 2008. Am J Gastroenterol. 2009;104(3):739-750.
5. Pignone M, Saha S, Hoerger T, Mandelblatt J. Costeffectiveness analyses of colorectal cancer screening: a systematic review for the US Preventive Services Task Force. Ann Intern Med. 2002;137(2):96-104.
6. Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116(3):544-573.
7. Ananthakrishnan AN, Schellhase KG, Sparapani RA, Laud PW, Neuner JM. Disparities in colon cancer screening in the Medicare population. Arch Intern Med. 2007;167(3):258-264.
8. O'Malley AS, Forrest CB, Feng S, Mandelblatt J. Disparities despite coverage: gaps in colorectal cancer screening among Medicare beneficiaries. Arch Intern Med. 2005;165(18):2129-2135.
9. Smedley BD, Stith AY, Nelson AR. Unequal treatment: confronting racial and ethnic disparities in health care. Available at: http://doi. apa. org/psycinfo/2003-02632-000. Accessed June 30, 2014.
10. US General Accounting Office. Private Health Insurance: Coverage of Key Colorectal Cancer Screening Tests Is Common but Not Universal: Report to the Ranking Minority Member, Committee on Health, Education, Labor and Pensions, US Senate. Washington, DC: US General Accounting Office; 2004.
11. Klabunde CN, Riley GF, Mandelson MT, Frame PS, Brown ML. Health plan policies and programs for colorectal cancer screening: a national profile. Am J Manag Care. 2004;10(4):273-279.
12. Goel MS, Wee CC, McCarthy EP, Davis RB, Ngo-Metzger Q, Phillips RS. Racial and ethnic disparities in cancer screening: the importance of foreign birth as a barrier to care. J Gen Intern Med. 2003;18(12): 1028-1035.
13. Jerant AF, Fenton JJ, Franks P. Determinants of racial/ethnic colorectal cancer screening disparities. Arch Intern Med. 2008;168(12):1317-1324.
14. Ioannou GN, Chapko MK, Dominitz JA. Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol. 2003;98(9):2082-2091.
15. Pollack LA, Blackman DK,Wilson KM, Seeff LC, Nadel MR. Colorectal cancer test use among Hispanic and non-Hispanic US populations. Prev Chronic Dis. 2006;3(2):A50.
16. Liss DT, Baker DW. Understanding current racial/ethnic disparities in colorectal cancer screening in the United States. Am J Prev Med. 2014;46(3):228-236.
17. Seeff LC, Nadel MR, Klabunde CN, et al. Patterns and predictors of colorectal cancer test use in the adult US population. Cancer. 2004;100(10):2093-2103.
18. James TM, Greiner KA, Ellerbeck EF, Feng C, Ahluwalia JS. Disparities in colorectal cancer screening: a guideline-based analysis of adherence. Ethn Dis. 2006;16 (1):228-233.
19. Wee CC, McCarthy EP, Phillips RS. Factors associated with colon cancer screening: the role of patient factors and physician counseling. Prev Med. 2005;41(1):23-29.
20. Cokkinides V, Bandi P, Shah M, Virgo K, Ward E. The association between state mandates of colorectal cancer screening coverage and colorectal cancer screening utilization among US adults aged 50 to 64 years with health insurance. BMC Health Serv Res. 2011;11(1):19.
21. Shih Y-CT, Zhao L, Elting LS. Does Medicare coverage of colonoscopy reduce racial/ethnic disparities in cancer screening among the elderly? Health Aff (Millwood). 2006;25(4):1153-1162.
22. Hamman MK, Kapinos KA. Colorectal cancer screening and state health insurance mandates. Health Econ. 2014;Epub ahead of print.
23. Xu W. Do state coverage mandates for preventive cancer screenings change behavior? Available at: https://ashecon. confex. com/ashecon/2014/webprogram/Paper2405. html. Accessed July 2, 2014.
24. Rao RS, Graubard BI, Breen N, Gastwirth JL. Understanding the factors underlying disparities in cancer screening rates using the Peters-Belson approach: results from the 1998 National Health Interview Survey. Med Care. 2004;42(8):789-800.
25. Fenton JJ, Tancredi DJ, Green P, Franks P, Baldwin L-M. Persistent racial and ethnic disparities in up-to-date colorectal cancer testing in Medicare enrollees. J Am Geriatr Soc. 2009;57(3):412-418.
26. White A, Vernon SW, Franzini L, Du XL. Racial and ethnic disparities in colorectal cancer screening persisted despite expansion of Medicare's screening reimbursement. Cancer Epidemiol Biomarkers Prev. 2011;20(5):811-817.
27. Gruber J. The incidence of mandated maternity benefits. Am Econ Rev. 1994;84(3):622-641.
28. Buchmueller T, Dinardo J. Did community rating induce an adverse selection death spiral? Evidence from New York, Pennsylvania, and Connecticut. Am Econ Rev. 2002;92(1):280-294.
29. Mahmoudi E, Jensen GA. Has Medicare Part D reduced racial/ethnic disparities in prescription drug use and spending? Health Serv Res. 2014;49(2):502-525.
30. Patient Protection and Affordable Care Act, 1 U. S. C. 2713 (2010).
31. Whitlock EP, Lin J, Liles E, et al. Screening for Colorectal Cancer: An Updated Systematic Review. Rockville, MD: Agency for Healthcare Research and Quality; 2008. Available at: http://www. ncbi. nlm. nih. gov/books/NBK35179. Accessed November 5, 2014.
32. Bitler MP, Carpenter CS. Effects of state cervical cancer insurance mandates on Pap test rates. Available at: http://www. socsci. uci. edu/;mbitler/papers/Bitler-Carpenter-Paps-07-17-2012-final2. pdf. Accessed August 1, 2014.
33. Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54(2):78-93.
34. National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch. Surveillance Epidemiology and End Results program SEERStat database: Mortality-all COD, aggregated with state, total US (1990-2011). Available at: http://www. cdc. gov/nchs. Accessed June 23, 2014.
35. Beydoun HA, Beydoun MA. Predictors of colorectal cancer screening behaviors among average-risk older adults in the United States. Cancer Causes Control. 2008;19 (4):339-359.
36. Carlos RC, Underwood W III, Fendrick AM, Bernstein SJ. Behavioral associations between prostate and colon cancer screening. J Am Coll Surg. 2005;200 (2):216-223.
37. Christman LK, Abdulla R, Jacobsen PB, et al. Colorectal cancer screening among a sample of community health center attendees. J Health Care Poor Underserved. 2004;15(2):281-293.
38. Meissner HI, Breen N, Klabunde CN, Vernon SW. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev. 2006;15(2):389-394.
39. Cokkinides VE, Chao A, Smith RA, Vernon SW, Thun MJ. Correlates of underutilization of colorectal cancer screening among US adults, age 50 years and older. Prev Med. 2003;36(1):85-91.
40. Centers for Disease Control and Prevention. Colorectal (colon) cancer: what are the risk factors? Available at: http://www. cdc. gov/cancer/colorectal/basic-info/risk-factors. htm. Accessed June 23, 2014.
41. Fairlie RW. An extension of the Blinder-Oaxaca decomposition technique to logit and probit models. J Econ Soc Meas. 2005;30(4):305-316.
42. StataCorp. Stata Statistical Software: Release 12 College Station, TX: StataCorp LP; 2011.
43. BertrandM,Duflo E,Mullainathan S. HowMuch Should We Trust Differences-in-Differences Estimates? Available at: http://www. nber. org/papers/w8841. Accessed November 9, 2014.
44. Wong ST, Gildengorin G, Nguyen T, Mock J. Disparities in colorectal cancer screening rates among Asian Americans and non-Latino Whites. Cancer. 2005;104(12 suppl):2940-2947.
45. Pollitz K, Lucia K, Keith K, et al. Coverage of colonoscopies under the Affordable Care Act's prevention benefit. Available at: http://kff. org/health-costs/report/coverage-of-colonoscopies-under-the-affordablecare. Accessed June 29, 2014.
46. Green BB, Coronado GD, Devoe JE, Allison J. Navigating the murky waters of colorectal cancer screening and health reform. Am J Public Health. 2014;104(6): 982-986.